Aktive Positionen von Daniel Deardorf
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Glycologix, Inc.
 Glycologix, Inc. BiotechnologyHealth Technology Glycologix, Inc. is an American biotechnology company that develops delivered biopolymers for the protection and repair of soft tissues. Glycologix was founded by Thomas Jozefiak and George Adaniya, and the CEO is Dan Deardorf. | Direktor/Vorstandsmitglied | - | - |
| Vorstandsvorsitzender | 01.01.2021 | - |
Karriereverlauf von Daniel Deardorf
Ehemalige bekannte Positionen von Daniel Deardorf
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| FLEXION THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand, an extended-release corticosteroid approved to manage osteoarthritis knee pain. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA. | Health Technology |
Glycologix, Inc.
Glycologix, Inc. BiotechnologyHealth Technology Glycologix, Inc. is an American biotechnology company that develops delivered biopolymers for the protection and repair of soft tissues. Glycologix was founded by Thomas Jozefiak and George Adaniya, and the CEO is Dan Deardorf. | Health Technology |
- Börse
- Insiders
- Daniel Deardorf
- Erfahrung
